WebJun 23, 2024 · Find everything you need to know about Stiolto Respimat 60 ACT, including what it is used for, warnings, reviews, side effects, and interactions. ... Generic Name: … WebBrand Name(s): Stiolto Respimat . ... The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be …
Sign Up For Support Stiolto® Respimat® Inhalation Spray
WebOct 12, 2024 · high blood sugar --increased thirst, increased urination, hunger, dry mouth, fruity breath odor; or. low potassium level --leg cramps, constipation, irregular heartbeats, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling. Common side effects may include: runny nose; cough; or. back pain. WebSelect your drug list name from the dropdown list. Then type in your medication name or view the full list. 3 Cigna National Preferred Prescription Drug List ATTENTION DEFICIT ... STIOLTO RESPIMAT fluticasone-salmeterol (By A-S MEDICATION, TEVA) fluticasone-salmeterol (by PRASCO, PROFICIENT RX), ADVAIR HFA, BREO ELLIPTA, la in tibetan
Stiolto Respimat (tiotropium / olodaterol): Basics, Side
WebThe generic name of Stiolto Respimat is tiotropium bromide and olodaterol. The product's dosage form is spray, metered and is administered via respiratory (inhalation) form. The product is distributed in 3 packages with assigned NDC codes 0597-0155-28 1 cartridge in 1 carton / 28 spray, metered in 1 cartridge, 0597-0155-61 1 cartridge in 1 ... WebBrand Name: Stiolto Respimat . Generic Name: tiotropium bromide and olodaterol . Manufacturer. 1: Boehringer Ingelheim . Drug Class. 1,2,3,4: long-acting anticholinergic (tiotropium bromide) and long-acting beta. 2-adrenergic agonist (olodaterol) Uses: Labeled Uses. 1,2,3,4: Maintenance treatment of chronic obstructive pulmonary disease WebMar 19, 2024 · DrugPatentWatch ® Generic Entry Outlook for Stiolto Respimat. Stiolto Respimat was eligible for patent challenges on July 31, 2024. By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be January 19, 2027. This may change due to patent challenges or generic licensing. Indicators of ... jemanalo webmail